Sanofi sues Actavis over generic version of heart drug Multaq

[Reuters] – French pharmaceutical company Sanofi has filed a lawsuit against Actavis over alleged patent infringements on its heart drug Multaq, hindering the generic drugmaker’s plans to produce its own version of the drug. Multaq generated sales of 269 more

View todays social media effects on ACT

View the latest stocks trending across Twitter. Click to view dashboard

See who Actavis is hiring next, click here to view